Literature DB >> 1856190

Isolation and characterization of a succinimide variant of methionyl human growth hormone.

G Teshima1, J T Stults, V Ling, E Canova-Davis.   

Abstract

Deamidation of asparagine and glutamine residues, isomerization of aspartic acid side chains, and racemization of the L- to the D-form of the amino acids are common spontaneous chemical reactions known to occur in proteins. Previous studies have implicated succinimides as intermediates in these reactions; however, the evidence has been indirect. Our results demonstrate, for the first time, the presence of a succinimide intermediate in an intact protein. The succinimide (cyclic imide) variant was isolated from thermally stressed recombinant methionyl human growth hormone (hGH) by high performance anion-exchange chromatography, further purified by reversed-phase high performance liquid chromatography, and analyzed by tryptic mapping. A later eluting tryptic peptide, compared with the native T12 peptide (residues 128-134, Leu-Glu-Asp-Gly-Ser-Pro-Arg), was analyzed by mass spectrometry (MS). This variant had a protonated molecular mass of 755.3 atomic mass units (u), as compared with 773.3 u for the native T12 peptide. A difference of 18 u, a loss of water, is consistent with the formation of a succinimide intermediate at Asp-130 of methionyl hGH. MS/MS analysis of the cyclic imide-containing peptide verified that the modification occurred at Asp-130. A difference of 18 u was also observed for the intact cyclic imide methionyl hGH variant (22,238 u), as measured by electrospray mass spectrometry, compared with native methionyl hGH (22,256 u).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1856190

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

Review 1.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

2.  The stabilization and encapsulation of human growth hormone into biodegradable microspheres.

Authors:  O L Johnson; W Jaworowicz; J L Cleland; L Bailey; M Charnis; E Duenas; C Wu; D Shepard; S Magil; T Last; A J Jones; S D Putney
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

3.  Analysis of isoaspartate in peptides by electrospray tandem mass spectrometry.

Authors:  W D Lehmann; A Schlosser; G Erben; R Pipkorn; D Bossemeyer; V Kinzel
Journal:  Protein Sci       Date:  2000-11       Impact factor: 6.725

4.  Mass spectrometric distinction of in-source and in-solution pyroglutamate and succinimide in proteins: a case study on rhG-CSF.

Authors:  Mukesh Kumar; Amarnath Chatterjee; Anand P Khedkar; Mutyalasetty Kusumanchi; Laxmi Adhikary
Journal:  J Am Soc Mass Spectrom       Date:  2013-01-03       Impact factor: 3.109

5.  The stability of recombinant human growth hormone in poly(lactic-co-glycolic acid) (PLGA) microspheres.

Authors:  J L Cleland; A Mac; B Boyd; J Yang; E T Duenas; D Yeung; D Brooks; C Hsu; H Chu; V Mukku; A J Jones
Journal:  Pharm Res       Date:  1997-04       Impact factor: 4.200

6.  Detection and quantitation of succinimide in intact protein via hydrazine trapping and chemical derivatization.

Authors:  Joshua J Klaene; Wenqin Ni; Joshua F Alfaro; Zhaohui Sunny Zhou
Journal:  J Pharm Sci       Date:  2014-07-14       Impact factor: 3.534

7.  Separation of oxidized variants of a monoclonal antibody by anion-exchange.

Authors:  Glen Teshima; Ming-Xiang Li; Rahima Danishmand; Chidi Obi; Robert To; Carol Huang; Jacob Kung; Vafa Lahidji; Joel Freeberg; Lauren Thorner; Milan Tomic
Journal:  J Chromatogr A       Date:  2010-11-16       Impact factor: 4.759

8.  Major degradation products of basic fibroblast growth factor: detection of succinimide and iso-aspartate in place of aspartate.

Authors:  Z Shahrokh; G Eberlein; D Buckley; M V Paranandi; D W Aswad; P Stratton; R Mischak; Y J Wang
Journal:  Pharm Res       Date:  1994-07       Impact factor: 4.200

9.  Isolation and characterization of porcine somatotropin containing a succinimide residue in place of aspartate129.

Authors:  B N Violand; M R Schlittler; E W Kolodziej; P C Toren; M A Cabonce; N R Siegel; K L Duffin; J F Zobel; C E Smith; J S Tou
Journal:  Protein Sci       Date:  1992-12       Impact factor: 6.725

10.  Simultaneous assessment of Asp isomerization and Asn deamidation in recombinant antibodies by LC-MS following incubation at elevated temperatures.

Authors:  Katharina Diepold; Katrin Bomans; Michael Wiedmann; Boris Zimmermann; Andreas Petzold; Tilman Schlothauer; Robert Mueller; Bernd Moritz; Jan Olaf Stracke; Michael Mølhøj; Dietmar Reusch; Patrick Bulau
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.